Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.24 USD
−27.31 M USD
248.69 M USD
56.73 M
About Strata Critical Medical, Inc.
Sector
Industry
CEO
Robert S. Wiesenthal
Website
Headquarters
New York
Founded
2014
ISIN
US0926671043
FIGI
BBG00Q3Q29N4
Strata Critical Medical, Inc., engages in the provision of logistics solutions and medical services to healthcare providers across the United States. It also offers air and ground transportation of human organs for transplant through the Trinity Medical Solutions brand. The company was founded by Robert S. Wiesenthal and Steven Martocci on December 22, 2014 and is headquartered in New York, NY.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Strata Critical Medical, Inc. stocks are traded under the ticker SRTA.
We've gathered analysts' opinions on Strata Critical Medical, Inc. future price: according to them, SRTA price has a max estimate of 6.50 USD and a min estimate of 5.00 USD. Watch SRTA chart and read a more detailed Strata Critical Medical, Inc. stock forecast: see what analysts think of Strata Critical Medical, Inc. and suggest that you do with its stocks.
Yes, you can track Strata Critical Medical, Inc. financials in yearly and quarterly reports right on TradingView.
Strata Critical Medical, Inc. is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
SRTA earnings for the last quarter are −0.05 USD per share, whereas the estimation was −0.04 USD resulting in a −16.65% surprise. The estimated earnings for the next quarter are 0.00 USD per share. See more details about Strata Critical Medical, Inc. earnings.
Strata Critical Medical, Inc. revenue for the last quarter amounts to 70.80 M USD, despite the estimated figure of 64.07 M USD. In the next quarter, revenue is expected to reach 79.87 M USD.
SRTA net income for the last quarter is −3.74 M USD, while the quarter before that showed −3.49 M USD of net income which accounts for −7.16% change. Track more Strata Critical Medical, Inc. financial stats to get the full picture.
No, SRTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 2, 2025, the company has 322 employees. See our rating of the largest employees — is Strata Critical Medical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Strata Critical Medical, Inc. EBITDA is −18.16 M USD, and current EBITDA margin is −8.93%. See more stats in Strata Critical Medical, Inc. financial statements.
Like other stocks, SRTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Strata Critical Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.